Identification of the novel allele, HLA‐B*48:58 , in a patient with chronic myelogenous leukemia
HLA · 2023
DOI: 10.1111/tan.15189 ↗Kurz gefasst
Fallbericht in der Zeitschrift HLA, 2023. Verfasst von Tongyuan Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Alleles, Exons, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, HLA-B Antigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
HLA‐B*48:58 differs from HLA‐B*48:01:01 by one nucleotide substitution in codon 17 in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zitieren
APA
Liu, T., Chen, L., Xiao, M., Wang, N., & Zhang, D. (2023). Identification of the novel allele, HLA‐B*48:58 , in a patient with chronic myelogenous leukemia. HLA. https://doi.org/10.1111/tan.15189
Vancouver
Liu T, Chen L, Xiao M, Wang N, Zhang D. Identification of the novel allele, HLA‐B*48:58 , in a patient with chronic myelogenous leukemia. HLA. 2023. doi:10.1111/tan.15189
BibTeX
@article{Liu2023,
author = {Liu, Tongyuan and Chen, Liting and Xiao, Min and Wang, Na and Zhang, Donghua},
title = {Identification of the novel allele, HLA‐B*48:58 , in a patient with chronic myelogenous leukemia},
journal = {HLA},
year = {2023},
doi = {10.1111/tan.15189}
}
EUVIMED